These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

2308 related articles for article (PubMed ID: 8206495)

  • 21. Generation and purification of CD8+ melan-A-specific cytotoxic T lymphocytes for adoptive transfer in tumor immunotherapy.
    Oelke M; Moehrle U; Chen JL; Behringer D; Cerundolo V; Lindemann A; Mackensen A
    Clin Cancer Res; 2000 May; 6(5):1997-2005. PubMed ID: 10815925
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [New aspects of human cancer immunology].
    Kikuchi K
    Nihon Seikeigeka Gakkai Zasshi; 1997 Jul; 71(7):292-303. PubMed ID: 9276876
    [No Abstract]   [Full Text] [Related]  

  • 23. Analysis of MAGE-3-specific cytolytic T lymphocytes in human leukocyte antigen-A2 melanoma patients.
    Valmori D; Liénard D; Waanders G; Rimoldi D; Cerottini JC; Romero P
    Cancer Res; 1997 Feb; 57(4):735-41. PubMed ID: 9044853
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A human endogenous retroviral sequence encoding an antigen recognized on melanoma by cytolytic T lymphocytes.
    Schiavetti F; Thonnard J; Colau D; Boon T; Coulie PG
    Cancer Res; 2002 Oct; 62(19):5510-6. PubMed ID: 12359761
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Melanoma antigen genes(MAGE) and malignant tumors].
    Xu JZ; Lin S
    Ai Zheng; 2003 Sep; 22(9):1001-4. PubMed ID: 12969539
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antigens recognized on human tumors by cytolytic T lymphocytes: towards vaccination?
    Coulie PG
    Stem Cells; 1995 Jul; 13(4):393-403. PubMed ID: 7549898
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of antigenic epitopes recognized by Mac-2 binding protein-specific cytotoxic T lymphocytes for use in cancer immunotherapy.
    Ozaki Y; Kontani K; Teramoto K; Fujita T; Tezuka N; Sawai S; Watanabe H; Fujino S; Asai T; Ohkubo I
    Biochem Biophys Res Commun; 2004 May; 317(4):1089-95. PubMed ID: 15094380
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Secretion of tumor-specific antigen by myeloma cells is required for cancer immunosurveillance by CD4+ T cells.
    Corthay A; Lundin KU; Lorvik KB; Hofgaard PO; Bogen B
    Cancer Res; 2009 Jul; 69(14):5901-7. PubMed ID: 19567679
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Enhancement by IL-12 of the cytolytic T lymphocyte (CTL) response of mice immunized with tumor-specific peptides in an adjuvant containing QS21 and MPL.
    Silla S; Fallarino F; Boon T; Uyttenhove C
    Eur Cytokine Netw; 1999 Jun; 10(2):181-90. PubMed ID: 10400824
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunodominance across HLA polymorphism: implications for cancer immunotherapy.
    Kim CJ; Parkinson DR; Marincola F
    J Immunother; 1998 Jan; 21(1):1-16. PubMed ID: 9456431
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Enhancement of cytolytic T lymphocyte precursor frequency in melanoma patients following immunization with the MAGE-1 peptide loaded antigen presenting cell-based vaccine.
    Hu X; Chakraborty NG; Sporn JR; Kurtzman SH; Ergin MT; Mukherji B
    Cancer Res; 1996 Jun; 56(11):2479-83. PubMed ID: 8653680
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The immunology of cancer.
    Angel Basombrío M
    J Oral Pathol; 1973; 2(5):231-53. PubMed ID: 4207800
    [No Abstract]   [Full Text] [Related]  

  • 33. Dual recognition of a human cytotoxic T-cell clone for melanoma antigens.
    Kubo H; Abe J; Obata F; Nakajima H; Tsunoda M; Ogawa A; Nakayama S; Beck Y; Kohsaka T; Darrow TL; Abdel-Wahab Z; Saida T; Takiguchi M
    Cancer Res; 1996 May; 56(10):2368-74. PubMed ID: 8625313
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Induction and functional analysis of cytotoxic T lymphocytes specific for the novel tumor-associated antigen CML66].
    Suemori K
    Rinsho Ketsueki; 2009 Aug; 50(8):604-10. PubMed ID: 19915374
    [No Abstract]   [Full Text] [Related]  

  • 35. Human tumour antigens recognized by T-cells: perspectives for new cancer vaccines.
    Van den Eynde B; Gaugler B; van der Bruggen P; Coulie P; Brichard V; Boon T
    Biochem Soc Trans; 1995 Aug; 23(3):681-6. PubMed ID: 8566443
    [No Abstract]   [Full Text] [Related]  

  • 36. Identification of a gene coding for a protein possessing shared tumor epitopes capable of inducing HLA-A24-restricted cytotoxic T lymphocytes in cancer patients.
    Yang D; Nakao M; Shichijo S; Sasatomi T; Takasu H; Matsumoto H; Mori K; Hayashi A; Yamana H; Shirouzu K; Itoh K
    Cancer Res; 1999 Aug; 59(16):4056-63. PubMed ID: 10463607
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clonal diversity of cytotoxic T lymphocytes that recognize autologous oral squamous cell carcinoma.
    Kobayashi J; Hirohashi Y; Torigoe T; Michifuri Y; Yamamoto T; Tamura Y; Kamiguchi K; Miyazaki A; Yamaguchi A; Hariu H; Hiratsuka H; Sato N
    Hum Immunol; 2009 Feb; 70(2):89-95. PubMed ID: 19124056
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The immunology of tumors.
    Burk MW; Mckhann CF
    Surg Annu; 1973; 5():1-29. PubMed ID: 4602210
    [No Abstract]   [Full Text] [Related]  

  • 39. Prospects for the immunotherapy of cancer. Part I: Basic concepts of tumor immunology.
    Pilch YH; Myers GH; Sparks FC; Golub SH
    Curr Probl Surg; 1975 Jan; ():1-46. PubMed ID: 236150
    [No Abstract]   [Full Text] [Related]  

  • 40. Tumor-associated and spontaneous lymphocyte-mediated cytotoxicity against cell lines derived from human urothelium.
    Vilien M
    Dan Med Bull; 1985 Aug; 32(4):199-218. PubMed ID: 3899526
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 116.